Report Detail
Global Influenza Subunit Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
- RnM4587787 |
- 21 May, 2024 |
- Global |
- 82 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Influenza subunit vaccine is a type of vaccine used to prevent influenza. It contains specific protein subunits of the influenza virus, usually the influenza virus hemagglutinin and neuraminidase. These subunits stimulate the body's immune system to produce antibodies that provide protection when infected with the influenza virus.
According to our (Global Info Research) latest study, the global Influenza Subunit Vaccine market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Influenza Subunit Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Influenza Subunit Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Influenza Subunit Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Influenza Subunit Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Influenza Subunit Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Influenza Subunit Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Influenza Subunit Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ab&B BIO-TECH, Sanofi, Seqirus, Inc, Zhongyianke Biology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Influenza Subunit Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Trivalent Vaccines
Tetravalent Vaccine
Market segment by Application
Aldult
Child
Major players covered
Ab&B BIO-TECH
Sanofi
Seqirus, Inc
Zhongyianke Biology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Influenza Subunit Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Influenza Subunit Vaccine, with price, sales quantity, revenue, and global market share of Influenza Subunit Vaccine from 2019 to 2024.
Chapter 3, the Influenza Subunit Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Influenza Subunit Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Influenza Subunit Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Influenza Subunit Vaccine.
Chapter 14 and 15, to describe Influenza Subunit Vaccine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Influenza Subunit Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Trivalent Vaccines
- 1.3.3 Tetravalent Vaccine
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Influenza Subunit Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Aldult
- 1.4.3 Child
- 1.5 Global Influenza Subunit Vaccine Market Size & Forecast
- 1.5.1 Global Influenza Subunit Vaccine Consumption Value (2019 & 2023 & 2030)
- 1.5.2 Global Influenza Subunit Vaccine Sales Quantity (2019-2030)
- 1.5.3 Global Influenza Subunit Vaccine Average Price (2019-2030)
2 Manufacturers Profiles
- 2.1 Ab&B BIO-TECH
- 2.1.1 Ab&B BIO-TECH Details
- 2.1.2 Ab&B BIO-TECH Major Business
- 2.1.3 Ab&B BIO-TECH Influenza Subunit Vaccine Product and Services
- 2.1.4 Ab&B BIO-TECH Influenza Subunit Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Ab&B BIO-TECH Recent Developments/Updates
- 2.2 Sanofi
- 2.2.1 Sanofi Details
- 2.2.2 Sanofi Major Business
- 2.2.3 Sanofi Influenza Subunit Vaccine Product and Services
- 2.2.4 Sanofi Influenza Subunit Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Sanofi Recent Developments/Updates
- 2.3 Seqirus, Inc
- 2.3.1 Seqirus, Inc Details
- 2.3.2 Seqirus, Inc Major Business
- 2.3.3 Seqirus, Inc Influenza Subunit Vaccine Product and Services
- 2.3.4 Seqirus, Inc Influenza Subunit Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Seqirus, Inc Recent Developments/Updates
- 2.4 Zhongyianke Biology
- 2.4.1 Zhongyianke Biology Details
- 2.4.2 Zhongyianke Biology Major Business
- 2.4.3 Zhongyianke Biology Influenza Subunit Vaccine Product and Services
- 2.4.4 Zhongyianke Biology Influenza Subunit Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Zhongyianke Biology Recent Developments/Updates
3 Competitive Environment: Influenza Subunit Vaccine by Manufacturer
- 3.1 Global Influenza Subunit Vaccine Sales Quantity by Manufacturer (2019-2024)
- 3.2 Global Influenza Subunit Vaccine Revenue by Manufacturer (2019-2024)
- 3.3 Global Influenza Subunit Vaccine Average Price by Manufacturer (2019-2024)
- 3.4 Market Share Analysis (2023)
- 3.4.1 Producer Shipments of Influenza Subunit Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
- 3.4.2 Top 3 Influenza Subunit Vaccine Manufacturer Market Share in 2023
- 3.4.3 Top 6 Influenza Subunit Vaccine Manufacturer Market Share in 2023
- 3.5 Influenza Subunit Vaccine Market: Overall Company Footprint Analysis
- 3.5.1 Influenza Subunit Vaccine Market: Region Footprint
- 3.5.2 Influenza Subunit Vaccine Market: Company Product Type Footprint
- 3.5.3 Influenza Subunit Vaccine Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Influenza Subunit Vaccine Market Size by Region
- 4.1.1 Global Influenza Subunit Vaccine Sales Quantity by Region (2019-2030)
- 4.1.2 Global Influenza Subunit Vaccine Consumption Value by Region (2019-2030)
- 4.1.3 Global Influenza Subunit Vaccine Average Price by Region (2019-2030)
- 4.2 North America Influenza Subunit Vaccine Consumption Value (2019-2030)
- 4.3 Europe Influenza Subunit Vaccine Consumption Value (2019-2030)
- 4.4 Asia-Pacific Influenza Subunit Vaccine Consumption Value (2019-2030)
- 4.5 South America Influenza Subunit Vaccine Consumption Value (2019-2030)
- 4.6 Middle East & Africa Influenza Subunit Vaccine Consumption Value (2019-2030)
5 Market Segment by Type
- 5.1 Global Influenza Subunit Vaccine Sales Quantity by Type (2019-2030)
- 5.2 Global Influenza Subunit Vaccine Consumption Value by Type (2019-2030)
- 5.3 Global Influenza Subunit Vaccine Average Price by Type (2019-2030)
6 Market Segment by Application
- 6.1 Global Influenza Subunit Vaccine Sales Quantity by Application (2019-2030)
- 6.2 Global Influenza Subunit Vaccine Consumption Value by Application (2019-2030)
- 6.3 Global Influenza Subunit Vaccine Average Price by Application (2019-2030)
7 North America
- 7.1 North America Influenza Subunit Vaccine Sales Quantity by Type (2019-2030)
- 7.2 North America Influenza Subunit Vaccine Sales Quantity by Application (2019-2030)
- 7.3 North America Influenza Subunit Vaccine Market Size by Country
- 7.3.1 North America Influenza Subunit Vaccine Sales Quantity by Country (2019-2030)
- 7.3.2 North America Influenza Subunit Vaccine Consumption Value by Country (2019-2030)
- 7.3.3 United States Market Size and Forecast (2019-2030)
- 7.3.4 Canada Market Size and Forecast (2019-2030)
- 7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
- 8.1 Europe Influenza Subunit Vaccine Sales Quantity by Type (2019-2030)
- 8.2 Europe Influenza Subunit Vaccine Sales Quantity by Application (2019-2030)
- 8.3 Europe Influenza Subunit Vaccine Market Size by Country
- 8.3.1 Europe Influenza Subunit Vaccine Sales Quantity by Country (2019-2030)
- 8.3.2 Europe Influenza Subunit Vaccine Consumption Value by Country (2019-2030)
- 8.3.3 Germany Market Size and Forecast (2019-2030)
- 8.3.4 France Market Size and Forecast (2019-2030)
- 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
- 8.3.6 Russia Market Size and Forecast (2019-2030)
- 8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
- 9.1 Asia-Pacific Influenza Subunit Vaccine Sales Quantity by Type (2019-2030)
- 9.2 Asia-Pacific Influenza Subunit Vaccine Sales Quantity by Application (2019-2030)
- 9.3 Asia-Pacific Influenza Subunit Vaccine Market Size by Region
- 9.3.1 Asia-Pacific Influenza Subunit Vaccine Sales Quantity by Region (2019-2030)
- 9.3.2 Asia-Pacific Influenza Subunit Vaccine Consumption Value by Region (2019-2030)
- 9.3.3 China Market Size and Forecast (2019-2030)
- 9.3.4 Japan Market Size and Forecast (2019-2030)
- 9.3.5 South Korea Market Size and Forecast (2019-2030)
- 9.3.6 India Market Size and Forecast (2019-2030)
- 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
- 9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
- 10.1 South America Influenza Subunit Vaccine Sales Quantity by Type (2019-2030)
- 10.2 South America Influenza Subunit Vaccine Sales Quantity by Application (2019-2030)
- 10.3 South America Influenza Subunit Vaccine Market Size by Country
- 10.3.1 South America Influenza Subunit Vaccine Sales Quantity by Country (2019-2030)
- 10.3.2 South America Influenza Subunit Vaccine Consumption Value by Country (2019-2030)
- 10.3.3 Brazil Market Size and Forecast (2019-2030)
- 10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
- 11.1 Middle East & Africa Influenza Subunit Vaccine Sales Quantity by Type (2019-2030)
- 11.2 Middle East & Africa Influenza Subunit Vaccine Sales Quantity by Application (2019-2030)
- 11.3 Middle East & Africa Influenza Subunit Vaccine Market Size by Country
- 11.3.1 Middle East & Africa Influenza Subunit Vaccine Sales Quantity by Country (2019-2030)
- 11.3.2 Middle East & Africa Influenza Subunit Vaccine Consumption Value by Country (2019-2030)
- 11.3.3 Turkey Market Size and Forecast (2019-2030)
- 11.3.4 Egypt Market Size and Forecast (2019-2030)
- 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
- 11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
- 12.1 Influenza Subunit Vaccine Market Drivers
- 12.2 Influenza Subunit Vaccine Market Restraints
- 12.3 Influenza Subunit Vaccine Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Influenza Subunit Vaccine and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Influenza Subunit Vaccine
- 13.3 Influenza Subunit Vaccine Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Influenza Subunit Vaccine Typical Distributors
- 14.3 Influenza Subunit Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Influenza Subunit Vaccine. Industry analysis & Market Report on Influenza Subunit Vaccine is a syndicated market report, published as Global Influenza Subunit Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Influenza Subunit Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
